Skip to main content
. 2020 Apr 20;12(4):378. doi: 10.3390/pharmaceutics12040378

Figure 6.

Figure 6

(A) Effect of delivery simulated conditions on 1.0% cyclosporine A stability in commercial and experimental eye drops formulations; * p < 0.05, T.amb versus 5 °C storage temperature. (B) Effect of delivery simulated conditions on 0.1% tacrolimus stability in commercial and experimental eye drops formulations; * p < 0.05, T.amb versus 5 °C storage temperature.